iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
1.510
0.00 (0.00%)
Jul 10, 2026, 4:00 PM EDT - Market closed
iBio, Inc. Market Cap
iBio, Inc. has a market cap or net worth of $75.01 million as of July 13, 2026. Its market cap has increased by 533.57% in one year.
Market Cap
75.01M
Enterprise Value
2.54M
1-Year Change
533.57%
Ranking
Category
Stock Price
$1.51
Market Cap Chart
Since August 19, 2008, iBio, Inc.'s market cap has increased from $14.01M to $75.01M, an increase of 435.34%. That is a compound annual growth rate of 9.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 75.01M | 72.84% |
| Dec 31, 2025 | 43.40M | 93.61% |
| Dec 31, 2024 | 22.42M | 716.05% |
| Dec 29, 2023 | 2.75M | -41.32% |
| Dec 30, 2022 | 4.68M | -96.09% |
| Dec 31, 2021 | 119.66M | -46.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entera Bio | 81.58M |
| Champions Oncology | 80.82M |
| Annovis Bio | 79.13M |
| Heron Therapeutics | 78.44M |
| Gain Therapeutics | 76.78M |
| OS Therapies | 74.82M |
| TScan Therapeutics | 71.23M |
| MindWalk Holdings | 71.02M |